Long-term sequelae of adverse pregnancy outcomes

Nare Torosyan1, Dalia Aziz2, Odayme Quesada3

  • 1Cedars-Sinai Smidt Heart Institute, Los Angeles, CA, United States of America.

Maturitas
|July 11, 2022
PubMed

Insights

Adverse pregnancy outcomes (APOs) like hypertensive disorders of pregnancy and gestational diabetes increase long-term cardiovascular disease (CVD) risk. Recognizing APOs is crucial for women's cardiovascular risk assessment and prevention strategies.

Area of Science:

  • Obstetrics and Gynecology
  • Cardiology
  • Public Health

Background:

  • Adverse pregnancy outcomes (APOs) are increasingly recognized as significant indicators of future cardiovascular disease (CVD) risk in women.
  • Current cardiovascular risk stratification often overlooks the long-term cardiovascular implications of pregnancy complications.

Purpose of the Study:

  • To conduct a comprehensive review of the long-term cardiovascular consequences associated with various APOs.
  • To emphasize the importance of incorporating APOs into women's cardiovascular disease risk assessment.

Main Methods:

  • Systematic literature review utilizing electronic databases, including PubMed and the Cochrane Library.
  • Analysis of studies examining the association between APOs (hypertensive disorders of pregnancy, preterm delivery, gestational diabetes, low birth weight, fetal growth restriction) and subsequent CVD.

Main Results:

  • Women experiencing APOs, particularly hypertensive disorders of pregnancy, preterm birth, and low birth weight, face a higher risk of developing CVD post-pregnancy.
  • Hypertensive disorders of pregnancy and gestational diabetes are identified as independent risk factors for atherosclerotic CVD, especially in women with multiple APOs.
  • The pathophysiology linking APOs to CVD is multifactorial, involving both physiological and environmental elements.

Conclusions:

  • Adverse pregnancy outcomes significantly elevate a woman's lifetime risk for cardiovascular disease.
  • APOs, including hypertensive disorders of pregnancy and gestational diabetes, should be integrated into routine cardiovascular risk assessment and stratification protocols for women.
  • Further research is warranted to elucidate the precise mechanisms underlying the increased CVD risk following APOs.

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.7K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
1.2K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.8K
Mitral Valve Prolapse III: Nursing Management01:19

Mitral Valve Prolapse III: Nursing Management

The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
34
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
2.6K
Ovarian Cycle01:27

Ovarian Cycle

The menstrual cycle includes a critical component known as the ovarian cycle, which undergoes two main phases each month—the follicular phase and the luteal phase. The follicular phase is variable and averaging around 14 days. Ovulation, triggered by a surge in luteinizing hormone (LH), marks the transition between the two phases. The second phase, the luteal phase, is relatively consistent, lasting approximately 14 days, and is marked by the activity of the corpus luteum. While a cycle...
1.8K